---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-039115"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2025-08-08T23:59:59+00:00"
generated_at: "2026-05-17T16:16:24.074004+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sanuwave Q2 revenue $10.2M (+42% YoY), adjusted EBITDA $3.4M; guides Q3 $12-12.7M

## Summary
- Q2 2025 revenue $10.2M, +42% YoY from $7.2M; gross margin 78.3% vs 73.2%.
- GAAP operating income $1.9M (incl $1.1M stock comp) vs $2.0M prior; adjusted EBITDA $3.4M vs $1.5M.
- Sold 116 UltraMist systems in Q2 (vs 72 Q2 2024); consumables revenue $6.4M, +37% YoY.
- Q3 2025 revenue guidance $12-12.7M; full-year 2025 reaffirmed $48-50M (47-53% growth).
- CEO says full national sales coverage achieved mid-July, aiming for breakout performance in Q4 2025 and 2026.

## SEC filing metadata
- accession: 0001628280-25-039115
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2025-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828025039115/0001628280-25-039115-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828025039115/snwv-20250808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-039115
- JSON: https://secwatch.observer/filing/0001628280-25-039115.json
- Plain text: https://secwatch.observer/filing/0001628280-25-039115.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.